Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features

Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review

(2016) A. D. Andersen et al.   ACTA NEUROLOGICA SCANDINAVICA

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

(2016) Ju-Hee Kang et al.   ACTA NEUROPATHOLOGICA

Alpha-Synuclein as a Biomarker for Parkinson's Disease

(2016) Anzari Atik et al.   BRAIN PATHOLOGY

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

(2016) Brit Mollenhauer et al.   JOURNAL OF NEUROCHEMISTRY

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

(2016) Franc Llorens et al.   JOURNAL OF NEUROLOGY

Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease

(2016) Corey T McMillan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression

(2016) Nour K. Majbour et al.   MOVEMENT DISORDERS

The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort

(2016) Un Jung Kang et al.   MOVEMENT DISORDERS

Biomarkers in Parkinson's disease: Advances and strategies

(2016) Marion Delenclos et al.   PARKINSONISM & RELATED DISORDERS

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients

(2016) Wenyan Kang et al.   Scientific Reports

Parkinson disease with REM sleep behavior disorder: Features,  -synuclein, and inflammation

(2015) Y. Hu et al.   NEUROLOGY

Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease

(2015) Ane Løvli Stav et al.   PARKINSONISM & RELATED DISORDERS

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s Disease

(2015) Ragnhild E. Skogseth et al.   Journal of Parkinsons Disease

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

(2014) Min Shi et al.   ACTA NEUROPATHOLOGICA

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Submandibular gland needle biopsy for the diagnosis of Parkinson disease

(2014) C. H. Adler et al.   NEUROLOGY

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

(2011) Lucilla Parnetti et al.   MOVEMENT DISORDERS

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

(2010) Jonathan Wills et al.   EXPERIMENTAL NEUROLOGY

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

(2009) Yaroslau Compta et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

(2008) Robin Barbour et al.   Neurodegenerative Diseases